APOPTOTIC DEATH IN T LYMPHOCYTES
APOPTOTIC DEATH IN T LYMPHOCYTES
批准号:
6100954
负责人:
P A HENKART
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
中文摘要
本项目旨在评估半胱天冬酶在T细胞死亡中的作用
英文摘要
This project aims to assess the role of caspases in T cell death
generally. In order to better study their functional role, we have
developed a new fluorogenic caspase substrate termed PhiPhiLux which can
detect caspase activation in intact apoptotic cells. This reagent is a
peptide derived from the caspase-3 cleavage site of poly-ADP- ribose
polymerase containing two rhodamine dyes substituted at the ends of the
peptide so that they form a self-quenched cyclic compound which is
disrupted by proteolytic cleavage. Extracts from apoptotic but not
normal thymocytes cleave this substrate after DEVD, and the fluorescence
increase is selectively blocked by caspase- 3 inhibitors. PhiPhiLux can
be loaded into intact thymocytes in vitro, and in response to apoptotic
stimuli thymocytes undergo a time-dependent about 10x increase in rhodamine
fluorescence by flow cytometry. This staining increase is specifically
blocked by preincubation with the caspase inhibitor ZVAD-FMK. Two-color
staining with FITC- annexin-V shows that PhiPhiLux+ cells are apoptotic
as seen by their exposed phosphatidyl serine. Confocal microscopy shows
that the PhiPhiLux stain is cytoplasmic and in T hybridomas treated with
staurosporine appears kinetically after the loss of mitochondrial psi.
In assessing the general importance of caspases in T cell death, we have
found that virtually all T cell death which is apoptotic by traditional
criteria can be specifically inhibited by peptide-FMK caspase
inhibitors. This includes the effect of a variety of chemotherapeutic
agents on T cell tumors. However, since tumor cell death assessed in
vitro may not be relevant to in vivo tumor eradication, we have tested
the ability of caspase inhibitors to block the ability of various agents
to decrease the formation of colonies in soft agar. Using both
chemotherapeutic agents and anti-Fas, we have been unable to observe a
blocking effect in this assay by either peptide-FMK or baculovirus p35
caspase inhibitors, even though they efficiently block traditional cell
death readouts in the same experiment. We are currently attempting to
ascertain whether these differences are due to the different kinetics
of the two types of assay, or whether inhibiting colony formation occurs
by a caspase-independent pathway even when triggered by Fas-
crosslinking.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
TARGET CELL DAMAGE BY IMMUNE MECHANISMS
-
批准号:3796537
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:P A HENKART
-
依托单位:
PROGRAMMED CELL DEATH IN LYMPHOCYTES
-
批准号:3774389
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:P A HENKART
-
依托单位:
TARGET CELL DAMAGE BY IMMUNE MECHANISMS
-
批准号:6161048
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:P A HENKART
-
依托单位:
PROGRAMMED CELL DEATH IN LYMPHOCYTES
-
批准号:3752092
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:P A HENKART
-
依托单位:
TARGET CELL DAMAGE BY IMMUNE MECHANISMS
-
批准号:3916398
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:P A HENKART
-
依托单位:
STRUCTURE AND FUNCTION OF CYTOTOXIC AND HELPER T LYMPHOCYTE GRANULES
-
批准号:3916408
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:P A HENKART
-
依托单位:
TARGET CELL DAMAGE BY IMMUNE MECHANISMS
-
批准号:3813453
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:P A HENKART
-
依托单位:
PROGRAMMED CELL DEATH IN LYMPHOCYTES
-
批准号:3796542
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:P A HENKART
-
依托单位:
MEMBRANE DAMAGE BY IMMUNE MECHANISMS
-
批准号:3962935
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:P A HENKART
-
依托单位:
APOPTOTIC DEATH IN T LYMPHOCYTES
-
批准号:6161054
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:P A HENKART
-
依托单位:
MEMBRANE DAMAGE BY IMMUNE MECHANISMS
-
批准号:4691749
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:P A HENKART
-
依托单位:
PROGRAMMED CELL DEATH IN LYMPHOCYTES
-
批准号:5201007
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:P A HENKART
-
依托单位:
TARGET CELL DAMAGE BY IMMUNE MECHANISMS
-
批准号:5201003
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:P A HENKART
-
依托单位:
STRUCTURE AND FUNCTION OF CYTOTOXIC T LYMPHOCYTE GRANULES
-
批准号:3939239
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:P A HENKART
-
依托单位:
TARGET CELL DAMAGE BY IMMUNE MECHANISMS
-
批准号:3774385
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:P A HENKART
-
依托单位:
TARGET CELL DAMAGE BY IMMUNE MECHANISMS
-
批准号:6100948
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:P A HENKART
-
依托单位:
STRUCTURE AND FUNCTION OF CYTOTOXIC T LYMPHOCYTE GRANULES
-
批准号:4691768
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:P A HENKART
-
依托单位:
TARGET CELL DAMAGE BY IMMUNE MECHANISMS
-
批准号:3808591
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:P A HENKART
-
依托单位:
STRUCTURE AND FUNCTION OF CYTOTOXIC T LYMPHOCYTE GRANULES
-
批准号:3962951
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:P A HENKART
-
依托单位:
TARGET CELL DAMAGE BY IMMUNE MECHANISMS
-
批准号:3752088
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:P A HENKART
-
依托单位:
海外基金